The role of connexins in prostate cancer promotion and progression

Nature Reviews Urology

Volumn 9, Issue 5, 2012, Pages 274-282

  Czyz, Jarosław ^a   Szpak, Katarzyna ^a   Madeja, Zbigniew ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 26; CONNEXIN 32; CONNEXIN 43; DOCETAXEL; GAP JUNCTION PROTEIN;

CANCER GROWTH; CARCINOGENESIS; CELL DIFFERENTIATION; CELL VIABILITY; GAP JUNCTION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; TUMOR PROMOTION;

CONNEXINS; DISEASE PROGRESSION; GAP JUNCTIONS; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84862156068     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.14     Document Type: Review

References (127)

1. Joshua, A. M. et al. Prostatic preneoplasia and beyond. Biochim. Biophys. Acta 1785, 156-181 (2008
2. Schröder, F. H. et al. Screening and prostate-cancer mortality in a randomized European study. N. Engl. J. Med. 360, 1320-1328 (2009
3. Siegel, R., Ward, E., Brawley, O. & Jemal, A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J. Clin. 61, 212-236 (2011
4. Sell, S. On the stem cell origin of cancer. Am. J. Pathol. 176, 2584-2594 (2010
5. Sottoriva, A. et al. Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Cancer Res. 70, 46-56 (2010
6. Lang, S. H., Frame, F. M. & Collins, A. T. Prostate cancer stem cells. J. Pathol. 217, 299-306 (2009
7. Maitland, N. J. & Collins, A. A tumour stem cell hypothesis for the origins of prostate cancer. BJU Int. 96, 1219-1223 (2005
8. Bonkhoff, H. & Remberger, K. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28, 98-106 (1996
9. Bonkhoff, H. Role of the basal cells in premalignant changes of the human prostate: a stem cell concept for the development of prostate cancer. Eur. Urol. 30, 201-205 (1996
10. Goldstein, A. S., Huang, J., Guo, C., Garraway, I. P. & Witte, O. N. Identification of a cell of origin for human prostate cancer. Science 329, 568-571 (2010
11. Nauseef, J. T. & Henry, M. D. Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle? Nat. Rev. Urol. 8, 428-439 (2011
12. Moore, K. A. & Lemischka, I. R. Stem cells and their niches. Science 311, 1880-1885 (2006
13. Voog, J. & Jones, D. L. Stem cells and the niche: a dynamic duo. Cell Stem Cell 6, 103-115 (2010
14. Mol, A. J., Geldof, A. A., Meijer, G. A., van der Poel, H. G. & van Moorselaar, R. J. New experimental markers for early detection of high-risk prostate cancer: role of cell-cell adhesion and cell migration. J. Cancer Res. Clin. Oncol. 133, 687-695 (2007
15. Wei, C. J., Xu, X. & Lo, C. W. Connexins and cell signaling in development and disease. Annu. Rev. Cell Dev. Biol. 20, 811-838 (2004
16. Trosko, J. E. Gap junctional intercellular communication as a biological "Rosetta stone" in understanding, in a systems biological manner, stem cell behavior, mechanisms of epigenetic toxicology, chemoprevention and chemotherapy. J. Membr. Biol. 218, 93-100 (2007
17. Loewenstein, W. R. Junctional intercellular communication and the control of growth. Biochim. Biophys. Acta 560, 1-65 (1979
18. Chipman, J. K., Mally, A. & Edwards, G. O. Disruption of gap junctions in toxicity and carcinogenicity. Toxicol. Sci. 71, 146-153 (2003
19. Luebeck, E. G., Buchmann, A., Schneider, D., Moolgavkar, S. H. & Schwarz, M. Modulation of liver tumorigenesis in connexin32-deficient mouse. Mutat. Res. 570, 33-47 (2005
20. Czyz, J. The stage-specific function of gap junctions during tumourigenesis. Cell. Mol. Biol. Lett. 13, 92-102 (2008
21. Cronier, L., Crespin, S., Strale, P. O., Defamie, N. & Mesnil, M. Gap junctions and cancer: new functions for an old story. Antioxid. Redox. Signal. 11, 323.338 (2009
22. Dbouk, H. A., Mroue, R. M., El-Sabban, M. E. & Talhouk, R. S. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun. Signal. 7, 4 (2009
23. Mroue, R. M., El-Sabban, M. E. & Talhouk, R. S. Connexins and the gap in context. Integr. Biol. (Camb.) 3, 255.266 (2011
24. Hossain, M. Z. et al. Impaired expression and posttranslational processing of connexin43 and downregulation of gap junctional communication in neoplastic human prostate cells. Prostate 38, 55.59 (1999
25. Habermann, H., Ray, V., Habermann, W. & Prins, G. S. Alterations in gap junction protein expression in human benign prostatic hyperplasia and prostate cancer. J. Urol. 167, 655.660 (2002
26. Miekus, K., Czernik, M., Sroka, J., Czyz., J. & Madeja, Z. Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Biol. Cell 97, 893.903 (2005
27. Tate, A. W. et al. Changes in gap junctional connexin isoforms during prostate cancer progression. Prostate 66, 19.31 (2006
28. Tarakanov, A. O. & Goncharova, L. B. Cell.cell nanotubes: Tunneling through several types of synapses. Commun. Integr. Biol. 2, 359.361 (2009
29. Maeda, S. & Tsukihara, T. Structure of the gap junction channel and its implications for its biological functions. Cell. Mol. Life Sci. 68, 1115.1129 (2011
30. Evans, W. H. & Martin, P. E. Gap junctions: structure and function (review). Mol. Membr. Biol. 19, 121.136 (2002
31. Burra, S. & Jiang, J. X. Regulation of cellular function by connexin hemichannels. Int. J. Biochem. Mol. Biol. 2, 119.128 (2011
32. Burra, S. et al. Dendritic processes of osteocytes are mechanotransducers that induce the opening of hemichannels. Proc. Natl Acad. Sci. USA 107, 13648.13653 (2010
33. Cotrina, M. L., Lin, J. H. & Nedergaard, M. Adhesive properties of connexin hemichannels. Glia 56, 1791.1798 (2008
34. Goldberg, G. S., Moreno, A. P. & Lampe, P. D. Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J. Biol. Chem. 277, 36725.36730 (2002
35. Salameh, A. Life cycle of connexins: regulation of connexin synthesis and degradation. Adv. Cardiol. 42, 57.70 (2006
36. Peracchia, C. Chemical gating of gap junction channels; roles of calcium, pH and calmodulin. Biochim. Biophys. Acta 1662, 61.80 (2004
37. Laird, D. W. Life cycle of connexins in health and disease. Biochem. J. 394, 527.543 (2006
38. Solan, J. L. & Lampe, P. D. Connexin43 phosphorylation: structural changes and biological effects. Biochem. J. 419, 261.272 (2009
39. Xu, X. et al. Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions. J. Cell Biol. 154, 217.230 (2001
40. Talhouk, R. S. et al. Heterocellular interaction enhances recruitment of α¿ and Á-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependent differentiation of mammary epithelial cells. Exp. Cell Res. 314, 3275.3291 (2008
41. Francis, R. et al. Connexin43 modulates cell polarity and directional cell migration by regulating microtubule dynamics. PLoS ONE 6, e26379 (2011
42. Elias, L. A., Wang, D. D. & Kriegstein, A. R. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 448, 901.907 (2007
43. Cina, C. et al. Involvement of the cytoplasmic C-terminal domain of connexin43 in neuronal migration. J. Neurosci. 29, 2009.2021 (2009
44. Zhang, Y. W., Nakayama, K., Nakayama, K. & Morita, I. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2). Cancer Res. 63, 1623.1630 (2003
45. Kardami, E. et al. The role of connexins in controlling cell growth and gene expression. Prog. Biophys. Mol. Biol. 94, 245.264 (2007
46. Dang, X., Doble, B. W. & Kardami, E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol. Cell Biochem. 242, 35.38 (2003
47. Jeronimo, C. et al. Epigenetics in prostate cancer: biologic and clinical relevance. Eur. Urol. 60, 753.766 (2011
48. Naus, C. C. & Laird, D. W. Implications and challenges of connexin connections to cancer. Nat. Rev. Cancer 10, 435.441 (2010
49. Leithe, E., Sirnes, S., Omori, Y. & Rivedal, E. Downregulation of gap junctions in cancer cells. Crit. Rev. Oncog. 12, 225.256 (2006
50. Zhu, D., Caveney, S., Kidder, G. M. & Naus, C. C. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc. Natl Acad. Sci. USA 88, 1883.1887 (1991
51. Chen, S. C., Pelletier, D. B., Ao, P. & Boynton, A. L. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ. 6, 681.690 (1995
52. Goldberg, G. S. et al. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res. 60, 6018.6026 (2000
53. Fujimoto, E. et al. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2. Mol. Carcinog. 40, 135.142 (2004
54. Mehta, P. P. et al. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev. Genet. 24, 91.110 (1999
55. Hirschi, K. K., Xu, C. E., Tsukamoto, T. & Sager, R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ. 7, 861.870 (1996
56. McLachlan, E., Shao, Q. & Laird, D. W. Connexins and gap junctions in mammary gland development and breast cancer progression. J. Membr. Biol. 218, 107.121 (2007
57. Trosko, J. E., Chang, C. C., Upham, B. L. & Tai, M. H. Ignored hallmarks of carcinogenesis: stem cells and cell-cell communication. Ann. NY Acad. Sci. 1028, 192.201 (2004
58. Graeber, S. H. & Hulser, D. F. Connexin transfection induces invasive properties in HeLa cells. Exp. Cell Res. 243, 142.149 (1998
59. Ito, A. et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J. Clin. Invest. 105, 1189.1197 (2000
60. Lin, J. H. et al. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J. Neurosci. 22, 4302.4311 (2002
61. Bates, D. C., Sin, W. C., Aftab, Q. & Naus, C. C. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus. Glia 55, 1554.1564 (2007
62. Ito, A. et al. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett. 234, 239.248 (2006
63. Kanczuga-Koda, L. et al. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J. Clin. Pathol. 59, 429.433 (2006
64. Baklaushev, V. P. et al. Visualization of connexin 43-positive cells of glioma and the periglioma zone by means of intravenously injected monoclonal antibodies. Drug Deliv. 18, 331.337 (2011
65. Han, Y. et al. Connexin43 expression increases in the epithelium and stroma along the colonic neoplastic progression pathway: implications for its oncogenic role. Gastroenterol. Res. Pract. 2011, 561719 (2011
66. Tang, B., Peng, Z. H., Yu, P. W., Yu, G. & Qian, F. Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes. Med. Oncol. 28, 502.508 (2011
67. Naoi, Y. et al. Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer. Breast Cancer Res. Treat. 106, 11.17 (2007
68. Lewalle, J. M., Cataldo, D., Bajou, K., Lambert, C. A. & Foidart, J. M. Endothelial cell intracellular Ca2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration. Clin. Exp. Metastasis 16, 21-29 (1998
69. Elzarrad, M. K. et al. Connexin-43 upregulation in micrometastases and tumor vasculature and its role in tumor cell attachment to pulmonary endothelium. BMC Med. 6, 20 (2008
70. Pollmann, M..A., Shao, Q., Laird, D. W. & Sandig, M. Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res. 7, R522.R534 (2005
71. Langley, R. R. & Fidler, I. J. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr. Rev. 28, 297.321 (2007
72. Yano, T. et al. Connexin 32 as an anti-invasive and anti-metastatic gene in renal cell carcinoma. Biol. Pharm. Bull. 29, 1991.1994 (2006
73. Sato, H. et al. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma. Mol. Carcinog. 47, 403.409 (2008
74. Li, Z., Zhou, Z., Welch, D. R. & Donahue, H. J. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin. Exp. Metastasis 25, 893.901 (2008
75. Xu, H. T. et al. Connexin 43 recruits E-cadherin expression and inhibits the malignant behaviour of lung cancer cells. Folia Histochem. Cytobiol. 46, 315.321 (2008
76. Liang, Q. L., Wang, B. R., Chen, G. Q., Li, G. H. & Xu, Y. Y. Clinical significance of vascular endothelial growth factor and connexin43 for predicting pancreatic cancer clinicopathologic parameters. Med. Oncol. 27, 1164.1170 (2010
77. Van der Aa, F., Roskams, T., Blyweert, W. & De Ridder, D. Interstitial cells in the human prostate: a new therapeutic target? Prostate 56, 250.255 (2003
78. Dey, A., Kusljic, S., Lang, R. J. & Exintaris, B. Role of connexin 43 in the maintenance of spontaneous activity in the guinea pig prostate gland. Br. J. Pharmacol. 161, 1692.1707 (2010
79. Bonkhoff, H. & Remberger, K. Morphogenetic aspects of normal and abnormal prostatic growth. Pathol. Res. Pract. 191, 833-835 (1995
80. El-Alfy, M., Pelletier, G., Hermo, L. S. & Labrie, F. Unique features of the basal cells of human prostate epithelium. Microsc. Res. Tech. 51, 436-446 (2000
81. Kyprianou, N. & Isaacs, J. T. Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgens. Endocrinology 123, 2124-2131 (1988
82. Sar, M., Lubahn, D. B., French, F. S. & Wilson, E. M. Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127, 3180-3186 (1990
83. Pointis, G., Fiorini, C., Defamie, N. & Segretain, D. Gap junctional communication in the male reproductive system. Biochim. Biophys. Acta 1719, 102-116 (2005
84. Meda, P. et al. Differential expression of gap junction connexins in endocrine and exocrine glands. Endocrinology 133, 2371-2378 (1993
85. Habermann, H., Chang, W. Y., Birch, L., Mehta, P. & Prins, G. S. Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. Endocrinology 142, 359-369 (2001
86. Gemel, J., Valiunas, V., Brink, P. R. & Beyer, E. C. Connexin43 and connexin26 form gap junctions, but not heteromeric channels in co-expressing cells. J. Cell Sci. 117, 2469-2480 (2004
87. Huynh, H. T. et al. Regulation of the gap junction connexin 43 gene by androgens in the prostate. J. Mol. Endocrinol. 26, 1-10 (2001
88. Prins, G. S. et al. Influence of neonatal estrogens on rat prostate development. Reprod. Fertil. Dev. 13, 241-252 (2001
89. Mitra, S. et al. Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cells. Mol. Biol. Cell 17, 5400-5416 (2006
90. Sottoriva, A., Sloot, P. M., Medema, J. P. & Vermeulen, L. Exploring cancer stem cell niche directed tumor growth. Cell Cycle 9, 1472-1479 (2010
91. Cocciadiferro, L. et al. Profiling cancer stem cells in androgen-responsive and refractory human prostate tumor cell lines. Ann. NY Acad. Sci. 1155, 257-262 (2009
92. Tsai, H. et al. Reduced connexin 43 expression in high grade, human prostatic adenocarcinoma cells. Biochem. Biophys. Res. Commun. 227, 64-69 (1996
93. Benko, G. et al. Prognostic value of connexin43 expression in patients with clinically localized prostate cancer. Prostate Cancer Prostatic Dis. 14, 90-95 (2011
94. Shackleton, M., Quintana, E., Fearon, E. R. & Morrison, S. J. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138, 822-829 (2009
95. Hernandez, M. et al. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. Prostate 66, 1151-1161 (2006
96. Chen, W. et al. ATRA enhances bystander effect of suicide gene therapy in the treatment of prostate cancer. Urol. Oncol. 26, 397-405 (2008
97. Carruba, G. et al. Intercellular communication and human prostate carcinogenesis. Ann. NY Acad. Sci. 963, 156-168 (2002
98. Carruba, G. et al. Regulation of cell-to-cell communication in non-tumorigenic and malignant human prostate epithelial cells. Prostate 50, 73-82 (2002
99. Tanaka, M. & Grossman, H. B. Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells. Oncol. Rep. 11, 537-541 (2004
100. Mehta, P. P. et al. Gap-junctional communication in normal and neoplastic prostate epithelial cells and its regulation by cAMP. Mol. Carcinog. 15, 18-32 (1996
101. Lamiche, C. et al. The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells. Clin. Exp. Metastasis 29, 111-122 (2012
102. Szpak, K. et al. DU-145 prostate carcinoma cells that selectively transmigrate narrow obstacles express elevated levels of Cx43. Cell. Mol. Biol. Lett. 16, 625-637 (2011
103. Saladino, F. et al. Connexin expression in nonneoplastic human prostate epithelial cells. Ann. NY Acad. Sci. 963, 213-217 (2002
104. Carter, H. B., Partin, A. W. & Coffey, D. S. Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface charge. J. Urol. 142, 1338-1341 (1989
105. Mie?kus, K. & Madeja, Z. Genistein inhibits the contact-stimulated migration of prostate cancer cells. Cell. Mol. Biol. Lett. 12, 348-361 (2007
106. Daniel-Wójcik, A. et al. Cell motility affects the intensity of gap junctional coupling in prostate carcinoma and melanoma cell populations. Int. J. Oncol. 33, 309-315 (2008
107. Olk, S., Zoidl, G. & Dermietzel, R. Connexins, cell motility, and the cytoskeleton. Cell. Motil. Cytoskeleton 66, 1000-1016 (2009
108. Kandouz, M. & Batist, G. Gap junctions and connexins as therapeutic targets in cancer. Expert Opin. Ther. Targets 14, 681-692 (2010
109. Clere, N., Faure, S., Martinez, M. C. & Andriantsitohaina, R. Anticancer properties of flavonoids: roles in various stages of carcinogenesis. Cardiovasc. Hematol. Agents Med. Chem. 9, 62-77 (2011
110. Nishiumi, S. et al. Dietary flavonoids as cancer-preventive and therapeutic biofactors. Front. Biosci. (Schol. Ed.) 3, 1332-1362 (2011
111. Chaumontet, C. et al. Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. Cancer Lett. 114, 207-210 (1997
112. Czyz?, J., Irmer, U., Zappe, C., Mauz, M. & Hülser, D. F. Hierarchy of carcinoma cell responses to apigenin: gap junctional coupling versus proliferation. Oncol. Rep. 11, 739-744 (2004
113. Czyz?, J., Madeja, Z., Irmer, U., Korohoda, W. & Hülser, D. F. Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int. J. Cancer 114, 12-18 (2005
114. King, T. J. & Bertram, J. S. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim. Biophys. Acta 1719, 146-160 (2005
115. Conklin, C. M. et al. Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells. Carcinogenesis 28, 93-100 (2007
116. Czernik, M., Sroka, J., Madeja, Z. & Czyz?, J. Apigenin inhibits growth and motility but increases gap junctional coupling intensity in rat prostate carcinoma (MAT-LyLu) cell populations. Cell. Mol. Biol. Lett. 13, 327-338 (2008
117. Wertz, K., Siler, U. & Goralczyk, R. Lycopene: modes of action to promote prostate health. Arch. Biochem. Biophys. 430, 127-134 (2004
118. Forbes, K., Gillette, K. & Sehgal, I. Lycopene increases urokinase receptor and fails to inhibit growth or connexin expression in a metastatically passaged prostate cancer cell line: a brief communication. Exp. Biol. Med. (Maywood) 228, 967-971 (2003
119. Gitenay, D. et al. Serum from rats fed red or yellow tomatoes induces Connexin43 expression independently from lycopene in a prostate cancer cell line. Biochem. Biophys. Res. Commun. 364, 578-582 (2007
120. Sell, S. Stem cell origin of cancer and differentiation therapy. Crit. Rev. Oncol. Hematol. 51, 1-28 (2004
121. Hattori, Y. & Maitani, Y. Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther. 12, 796-809 (2005
122. Wang, M., Berthoud, V. M. & Beyer, E. C. Connexin43 increases the sensitivity of prostate cancer cells to TNFα-induced apoptosis. J. Cell Sci. 120, 320-329 (2007
123. Govindarajan, R. et al. Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by α-catenin. J. Biol. Chem. 277, 50087-50097 (2002
124. Fukushima, M., Hattori, Y., Yoshizawa, T. & Maitani, Y. Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice. Int. J. Oncol. 30, 225-231 (2007
125. Wybieralska, E. et al. Fenofibrate attenuates contact-stimulated cell motility and gap junctional coupling in DU-145 human prostate cancer cell populations. Oncol. Rep. 26, 447-453 (2011
126. Chao, Y., Wu, Q., Acquafondata, M., Dhir, R. & Wells, A. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron. http://dx.doi.org/10.1007/s12307-011-0085-4.
127. Kedrin, D., Wyckoff, J., Sahai, E., Condeelis, J. & Segall, J. E. Imaging tumor cell movement in vivo. Curr. Protoc. Cell Biol. 35, 19.7.1-19.7.17 (2007)